SCHEMBL2373767

SCHEMBL2373767

CCCCCCC(CCC)C(CCCCCC)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.53
FFAR1 O14842 2/20 0.53
MAPT P10636 1/20 0.52
LCK P06239 1/20 0.52
PPARD Q03181 1/20 0.52
ZDHHC20 Q5W0Z9 1/20 0.52
ZDHHC2 Q9UIJ5 1/20 0.52
ACE2 Q9BYF1 1/20 0.48
CA2 P00918 1/20 0.46
GRIK1 P39086 2/20 0.44
GRIK2 Q13002 2/20 0.44
FFAR4 Q5NUL3 1/20 0.44
ZDHHC7 Q9NXF8 1/20 0.43
ALDH1A1 P00352 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL626862 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL4587471 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL626770 0.98 GPR84 (0.52) GPR84FFAR1MAPTLCKPPARD
SCHEMBL6245878 0.96 GPR84 (0.57) GPR84FFAR1MAPTLCKPPARD
SCHEMBL17685264 0.96 GPR84 (0.57) GPR84FFAR1MAPTLCKPPARD
SCHEMBL268638 0.96 GPR84 (0.57) GPR84FFAR1MAPTLCKPPARD
SCHEMBL9770059 0.96 GPR84 (0.57) GPR84FFAR1MAPTLCKPPARD
SCHEMBL62996 0.96 GPR84 (0.57) GPR84FFAR1MAPTLCKPPARD
SCHEMBL16816949 0.96 GPR84 (0.57) GPR84FFAR1MAPTLCKPPARD
SCHEMBL14695713 0.96 GPR84 (0.57) GPR84FFAR1MAPTLCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4319884-B1 COSMETIC COMPOSITION COMPRISING HINOKITIOL UNILEVER IP HOLDINGS B V (NL) 2026-05-27 EP claimed
EP-3833447-B1 ANHYDROUS COSMETIC COMPOSITION COMPRISING VEGETABLE OIL CLARINS LAB (FR) 2025-02-26 EP claimed
EP-3923900-B1 ODOR-STABLE ETHANOLIC PREPARATION CONTAINING OCTOCRYLENE BEIERSDORF AG (DE) 2023-12-27 EP claimed
EP-3714865-B1 COSMETIC COMPOSITION WITH HIGH CONTENT OF TRIAZINE DERIVATIVE SOLAR FILTERS THOREL JEAN NOEL (FR) 2023-08-02 EP claimed
EP-3419588-B1 COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX OUTPLAY INC (US) 2023-04-05 EP claimed
EP-4025178-B1 NOVEL SYSTEM FOR SOLUBILISING FAT-SOLUBLE ORGANIC SUN FILTERS FABRE PIERRE DERMO COSMETIQUE (FR) 2023-01-18 EP claimed
EP-3923900-A1 ODOR-STABLE ETHANOLIC PREPARATION CONTAINING OCTOCRYLENE Beiersdorf AG (DE) 2021-12-22 EP claimed
CN-109379887-B Topical compositions based on carnosine-magnesium complexes 完胜股份有限公司 2021-12-21 CN claimed
US-10973868-B2 Composition for topical use based on a carnosine-magnesium complex OUTPLAY, INC. 2021-04-13 US claimed
EP-3258942-B1 COSMETIC AND TOPICAL COMPOSITIONS COMPRISING CANNABIGEROL AND CANNABIDIOL APIRX PHARMACEUTICAL USA LLC (US) 2021-01-13 EP claimed
US-20190216880-A1 COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX OUTPLAY INC. (CA) 2019-07-18 US claimed
EP-3437626-A1 SUNSCREEN WITH LOW EYE IRRITATION POTENTIAL Beiersdorf AG (DE) 2019-02-06 EP claimed
EP-3419588-A1 COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX Outplay Inc. (CA) 2019-01-02 EP claimed
EP-2750680-B1 COMPOSITION FOR TREATING LICE INFESTATION LEVIN ORNA (IL) 2018-12-26 EP claimed
EP-3056192-B1 Complete anhydrous sunscreen composition with under water technology FREZYDERM S A (GR) 2018-11-21 EP claimed
EP-2934462-B1 TWO-PHASE DEVELOPER FOR OXIDATIVE COLOR CHANGING AGENTS HENKEL AG & CO KGAA (DE) 2017-11-29 EP claimed
WO-2017145030-A1 COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX OUTPLAY INC. (CA) 2017-08-31 WO claimed
WO-2017144937-A1 COMPOSITIONS FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX OUTPLAY INC. (CA) 2017-08-31 WO claimed
EP-2783690-B1 NEW USE OF NEOHESPERIDIN NATURAL MEDICINE INST ZHEJIANG YANGSHENGTANG CO LTD (CN) 2017-04-26 EP claimed
EP-2456445-B1 AGENT FOR THE TREATMENT OF SKIN CONDITIONS POHL BOSKAMP G GMBH & CO KG (DE) 2014-05-14 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10973868-B2 Composition for topical use based on a carnosine-magnesium complex CKMT1A; CKMT1B, S100A6, S100A4 GPR84 1025/4885FFAR1 3817/4885MAPT 2133/4885
US-20190216880-A1 COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX CKMT1A; CKMT1B, S100A6, S100A4 GPR84 1025/4885FFAR1 3817/4885MAPT 2133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.